About ATH
Alterity Therapeutics Limited (ATH, formerly Prana Biotechnology Limited) is a clinical stage biotechnology company focused on neurodegenerative diseases. The company focusses to commercialise research into Parkinsonian movement disorders, Alzheimer disease, Huntington disease and other neurodegenerative disorders.
Find out what a historical investment in Alterity Therapeutics Limited would be worth today using our ATH stock calculator.
Market Capitalisation
$94M
Price-earnings ratio
-3.69
Dividend yield
-
High today
$0.42
Low today
$0.38
Open price
$0.40
52-week high
$0.79
52-week low
$0.35
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ATH
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in ATH on Stake
- Buy ATH from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
ATH related stocks